HTA323 Understanding the Pricing and Reimbursement Outcomes of Advanced Therapy Medicinal Products (ATMP) in Spain von Vico, T, Águila Fuentes, M, Hernaez Colque, M, De La Paz Cañizares, I, Castillo, C

Volltext

EE203 Budget Impact Analysis of Ublituximab as a Maintenance Treatment for Relapsing Multiple Sclerosis (RMS) in Spain von Le Rouzo, G, Conde Galán, C, Hernaez Colque, M, Aguado, M, Castillo, C

Volltext

EE364 Cost-Effectiveness Analysis of Difelikefalin for the Treatment of Chronic Kidney Disease Associated-Pruritus in Spain von Sánchez-Álvarez, Emilio, E, Poveda, JL, Sanchez-Villanueva, R., de Arellano Serna A, Ramirez, Olga, R, La Paz Cañizares I, De, Hernaez Colque, M

Volltext

HSD91 Integrated Care Process and Pharmacological Prescription for Patients With Hypercholesterolemia or Mixed Dyslipidemia at High or Very High Cardiovascular Risk in Catalonia von De La Paz Cañizares, I, Josep Maria, GS, Hernaez Colque, M, Marzo, I, García López, V, Cristina, C, Gema, Y, Zamora, A, Núria, S

Volltext

HPR144 Support of RWE in the Price and Reimbursement Decision-Making Process for Rare Diseases in Spain von De La Paz Cañizares, I., Saborido, C., Fontanet, M., Calleja, MÁ, Martínez-Sesmero, J.M., Sala Piñol, F., Asensio, I., Hernaez Colque, M., Ferrandez, O., Castillo, C.

Volltext